← Leaderboards
Sana Raoof
Harvard Medical School
$135,072
Attributed
$135,072
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.5K · FY2017–19$50K$37.5K$25K$12.5K$0
'17
'18
'19
Funding mix
By agency
NIH$135,072 · 1
By mechanism
F30$135,072 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Markus Thomas Basan$2,763,211
- Carlos Federico Lopez$1,806,568
- Nathalie Yr Agar$10,055,254
- Danica Galonic Fujimori$12,238,379
- Aedin C Culhane$2,653,443
Others in their field
Other Emerging Leaders on “Apoptosis”
- Deanna A Kulpa · Emory University$8,444,989
- Yamuna Krishnan · University Of Chicago$5,740,000
- Peter J Leary · University Of Washington$5,643,326
- Tanya Christineh Petrossian · Endomet Biosciences, Inc$4,570,776
- Yanbo Fan · University Of Cincinnati$4,484,838
- William Raymond Lagor · Baylor College Of Medicine$4,366,036
Research focus
ApoptosisAutomobile DrivingAwarenessBaseBiologicalCancer CellCancer EtiologyCancer PatientCancer TherapyCancer TypeCell LineCellsCell SurvivalCell TherapyCessation Of LifeChemotherapyChip-SeqChromatinChromatin ModificationDisease ModelDropoutDrug CandidateDrug CombinationsDrug Resistance
Grant awards (3)
Drug Tolerant Persisters in EGFR-mutant Non-small Cell Lung Cancer: Epigenetic Landscape and Therapeutic Targeting$47,948
F30 · FY2019 · CA · contact PI
Drug Tolerant Persisters in EGFR-mutant Non-small Cell Lung Cancer: Epigenetic Landscape and Therapeutic Targeting$49,524
F30 · FY2018 · CA · contact PI
Drug Tolerant Persisters in EGFR-mutant Non-small Cell Lung Cancer: Epigenetic Landscape and Therapeutic Targeting$37,600
F30 · FY2017 · CA · contact PI